OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study
Sibylle de Germay, Cécile Conte, Olivier Rascol, et al.
CNS Drugs (2020) Vol. 34, Iss. 7, pp. 763-772
Closed Access | Times Cited: 12
Sibylle de Germay, Cécile Conte, Olivier Rascol, et al.
CNS Drugs (2020) Vol. 34, Iss. 7, pp. 763-772
Closed Access | Times Cited: 12
Showing 12 citing articles:
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 32
Divya Yadav, Pravir Kumar
Neurochemistry International (2022) Vol. 156, pp. 105327-105327
Closed Access | Times Cited: 32
Association Between β‐Adrenoreceptor Agonists and Antagonists and Parkinson's Disease: Systematic Review and Meta‐Analysis
Agnieszka Szmigiel, M Rocha, K Browne, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 4
Open Access
Agnieszka Szmigiel, M Rocha, K Browne, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 4
Open Access
Beta-adrenergic drugs and risk of Parkinson’s disease: A systematic review and meta-analysis
Ambrish Singh, Salman Hussain, Sreelatha Akkala, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101670-101670
Open Access | Times Cited: 11
Ambrish Singh, Salman Hussain, Sreelatha Akkala, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101670-101670
Open Access | Times Cited: 11
Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence
Zeying Feng, Qiuping Zhao, Jingjing Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Zeying Feng, Qiuping Zhao, Jingjing Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
Joseph R. Patterson, Warren D. Hirst, Jacob W. Howe, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Joseph R. Patterson, Warren D. Hirst, Jacob W. Howe, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
E. Courtois, Thi Thu Ha Nguyen, A. Fournier, et al.
Movement Disorders (2022) Vol. 37, Iss. 12, pp. 2376-2385
Open Access | Times Cited: 9
E. Courtois, Thi Thu Ha Nguyen, A. Fournier, et al.
Movement Disorders (2022) Vol. 37, Iss. 12, pp. 2376-2385
Open Access | Times Cited: 9
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
Anne Paakinaho, Miia Tiihonen, Heikki Koskela, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 695-705
Open Access | Times Cited: 5
Anne Paakinaho, Miia Tiihonen, Heikki Koskela, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 695-705
Open Access | Times Cited: 5
Association between β2-Adrenoreceptor Medications and Risk of Parkinson’s Disease: A Meta-Analysis
Chu-Ling Chen, Shuyi Wang, Ta-Cheng Chen, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1006-1006
Open Access | Times Cited: 12
Chu-Ling Chen, Shuyi Wang, Ta-Cheng Chen, et al.
Medicina (2021) Vol. 57, Iss. 10, pp. 1006-1006
Open Access | Times Cited: 12
Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease
Julia Tuominen, Kjetil Bjørnevik, Julia Romanowska, et al.
Parkinsonism & Related Disorders (2023) Vol. 110, pp. 105389-105389
Open Access | Times Cited: 4
Julia Tuominen, Kjetil Bjørnevik, Julia Romanowska, et al.
Parkinsonism & Related Disorders (2023) Vol. 110, pp. 105389-105389
Open Access | Times Cited: 4
Shared Molecular Targets in Parkinson’s Disease and Arterial Hypertension: A Systematic Review
Delia Tulbă, Mioara Avasilichioaiei, Natalia Dima, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 653-653
Open Access | Times Cited: 5
Delia Tulbă, Mioara Avasilichioaiei, Natalia Dima, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 653-653
Open Access | Times Cited: 5
The association between developing Parkinson's disease and β-Adrenoceptor acting agents use: A systematic review and meta-analysis
Weerawat Saengphatrachai, Kulsatree Praditukrit, Weerapat Owattanapanich, et al.
Journal of the Neurological Sciences (2021) Vol. 430, pp. 120009-120009
Closed Access | Times Cited: 7
Weerawat Saengphatrachai, Kulsatree Praditukrit, Weerapat Owattanapanich, et al.
Journal of the Neurological Sciences (2021) Vol. 430, pp. 120009-120009
Closed Access | Times Cited: 7
Systematic Review and Meta-Analysis Protocol: Beta adrenoreceptor drugs and risk of Parkinson’s disease
Ambrish Singh, Salman Hussain, Sreelatha Akkala, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Ambrish Singh, Salman Hussain, Sreelatha Akkala, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
